Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Return on Sales (2017 - 2018)

Historic Return on Sales for ENDRA Life Sciences (NDRA) over the last 3 years, with Q4 2018 value amounting to 1586.7%.

  • ENDRA Life Sciences' Return on Sales fell 12517100.0% to 1586.7% in Q4 2018 from the same period last year, while for Dec 2018 it was 1586.7%, marking a year-over-year decrease of 15714000.0%. This contributed to the annual value of 106.08% for FY2024, which is 842300.0% down from last year.
  • According to the latest figures from Q4 2018, ENDRA Life Sciences' Return on Sales is 1586.7%, which was down 12517100.0% from 746.72% recorded in Q3 2018.
  • In the past 5 years, ENDRA Life Sciences' Return on Sales ranged from a high of 3.11% in Q2 2016 and a low of 1586.7% during Q4 2018
  • For the 3-year period, ENDRA Life Sciences' Return on Sales averaged around 318.96%, with its median value being 25.52% (2017).
  • Data for ENDRA Life Sciences' Return on Sales shows a peak YoY increase of -14700bps (in 2018) and a maximum YoY decrease of -12517100bps (in 2018) over the last 5 years.
  • ENDRA Life Sciences' Return on Sales (Quarter) stood at 1.34% in 2016, then tumbled by -24971bps to 334.98% in 2017, then plummeted by -374bps to 1586.7% in 2018.
  • Its last three reported values are 1586.7% in Q4 2018, 746.72% for Q3 2018, and 26.25% during Q2 2018.